Keyphrases
Breast Cancer
60%
Neoadjuvant Chemotherapy
55%
Immunohistochemistry
39%
Invasive Breast Cancer
34%
Malignancy
32%
Indonesia
32%
Cervical Cancer
32%
Invasive Breast Carcinoma of No Special Type
30%
Ovarian Cancer
27%
CD44+
27%
CD24
27%
Invasive Breast Carcinoma
27%
Lymph Node Metastasis
27%
Tumor-infiltrating Lymphocytes
27%
Metastasis
26%
Clinical Response
22%
Flow Cytometry
21%
Cancer Resistance
21%
Randomized Controlled Trial
19%
Cancer Stem Cells
19%
DDB2
18%
Rad6
18%
Early-stage Cervical Cancer
18%
AKT2
18%
Survivin Expression
18%
Atypical Ductal Hyperplasia
18%
Cyclin D1 (CCND1)
18%
Secretory Carcinoma
18%
E-cadherin
18%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
18%
Fas Ligand
18%
Curcumin
18%
Rare Case Report
18%
No Special Type
18%
Breast
17%
Survivin
16%
Melatonin
15%
Human Epidermal Growth Factor Receptor 2 (HER2)
14%
CD4+
13%
Jakarta
13%
Locally Advanced
13%
Mucinous
13%
Tumor
13%
Paraffin Blocks
11%
Apoptosis
11%
Pelvic Lymph Node Metastasis
11%
Invasive Ductal Carcinoma
11%
Response Predictors
11%
Mucin
11%
Antiproliferative Activity
10%
Medicine and Dentistry
Breast Cancer
64%
Breast Carcinoma
55%
Lymph Node Metastasis
48%
Immunohistochemistry
46%
Cervical Cancer
40%
Ovarian Cancer
37%
Drug Resistance
34%
Neoplasm
29%
Cancer Stem Cell
28%
Biopsy
19%
Flow Cytometry
18%
Survivin
18%
Scoring System
18%
Carcinoma
18%
Tumor Infiltrating Lymphocyte
18%
Neoadjuvant Chemotherapy
18%
Pelvis
16%
Radiation Therapy
13%
Metastatic Carcinoma
11%
Mucin
11%
Histopathology
11%
Invasive Carcinoma
11%
Laparotomy
10%
Randomized Controlled Trial
10%
Oral Cavity
10%
Placebo
10%
Gynecology
10%
Obstetrics
10%
microRNA 210
9%
Placenta Malaria
9%
Melatonin
9%
Anemia
9%
Pseudomyxoma Peritonei
9%
Stromal Tumor
9%
Cystadenoma
9%
Flap (Surgery)
9%
Krukenberg Tumor
9%
Infection
9%
Allele
9%
Matrix Metalloproteinase 14
9%
Axillary Lymph Node
9%
CD44v Antigen
9%
Granulosa Cell Tumour
9%
Uvomorulin
9%
Integrin
9%
Endometrial Cancer
9%
Fas Ligand
9%
Caspase 3
9%
Intention-to-Treat Analysis
9%
Diagnostic Accuracy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy
76%
Malignant Neoplasm
62%
Neoplasm
46%
Ovary Cancer
37%
Uterine Cervix Cancer
37%
Drug Resistance
36%
Breast Carcinoma
30%
Caspase 3
21%
Flow Cytometry
20%
Lymph Node Metastasis
20%
Randomized Controlled Trial
20%
Cyclin D1
18%
Melatonin
18%
Survivin
18%
Fas Ligand
18%
Mouth Squamous Cell Carcinoma
18%
Curcumin
18%
CD8 Antigen
14%
Biological Marker
12%
Placebo
11%
Estrogen Receptor
10%
Taxane
9%
Hypoxia Inducible Factor
9%
microRNA 210
9%
Soybean Extract
9%
Anthracycline
9%
Matrix Metalloproteinase 14
9%
Atypical Ductal Hyperplasia
9%
Uvomorulin
9%
Radiosensitizing Agent
9%
Tensin
9%
Phosphatase
9%
Malonaldehyde
9%
Hypoxia Inducible Factor 1
7%
Carcinoma
5%
Primary Tumor
5%
Dimethylbenz[a]anthracene
5%
Carcinogenesis
5%